Lactate production

Lactate production on a stool microbiome panel estimates your gut community's capacity to make lactate from carbohydrates. It uses whole-genome sequencing of microbial DNA to identify bacteria and their functional potential. The result doesn't measure the amount of lactate in your stool, the speed of fermentation, or the acidity of your gut.

This is a research-stage marker. Its value for diagnosing disease, choosing treatment, or predicting future symptoms hasn't been established. A higher or lower result has no proven health meaning on its own.

How Gut Bacteria Make and Recycle Lactate

Lactate is a small molecule made during the breakdown of sugars. Bifidobacterium, Lactobacillus, and Streptococcus include species that produce it in the gut. Other bacteria consume it: Anaerobutyricum species can turn lactate into butyrate, while Veillonella and Coprococcus catus can produce propionate.

Butyrate and propionate are short-chain fatty acids made during microbial fermentation. Butyrate is an important fuel for the cells lining your colon. Much of the lactate produced in an adult colon is used by other microbes before it reaches stool, so production capacity and the amount left in stool can differ substantially.

Laboratory models using human fecal microbes show that acidity and the time available for fermentation affect this recycling. Under some conditions, lactate accumulates and production of other fermentation products falls. These experiments explain a possible mechanism; they don't establish that a high production score means this is happening in your gut.

Lactate comes in two mirror-image forms, L-lactate and D-lactate. Your cells make mostly the L form, though they also produce small amounts of D-lactate. Bacteria can make either or both. A total production estimate doesn't establish how much of either form is present or how much enters your bloodstream.

Short Bowel Syndrome and D-Lactic Acidosis

After extensive removal of the small intestine, carbohydrates that escape absorption can reach the remaining colon and undergo fermentation. In some people, bacterial D-lactate production contributes to episodes of excessive blood acidity and neurological symptoms. This is an established complication of short bowel syndrome, but a stool production score hasn't been validated to diagnose or predict it.

A study of 16 adults with short bowel syndrome measured D- and L-lactate directly in stool. Nine accumulated lactate. Some participants had a history of neurological episodes attributed to D-lactic acidosis. The researchers proposed the stool D-to-L ratio as a possible risk marker; the small study didn't establish a diagnostic test.

Ulcerative Colitis

In a study of 62 people with ulcerative colitis, directly measured lactate in fecal water was about seven times higher in severe disease than in mild disease. Severe disease also came with more acidic stool and lower concentrations of short-chain fatty acids. These were measurements of stool chemistry, which are different from the DNA-based production estimate reported here.

Inflammation can change the conditions in which gut microbes grow and ferment. The study shows an association between active disease and lactate accumulation. It doesn't establish whether lactate caused the inflammation or whether this production score can detect a flare.

Lactose Intolerance

Lactose that isn't absorbed in the small intestine can be fermented by colonic bacteria. In one study, 28 adults underwent lactose challenges, and stool from 12 with consistent symptom classifications was selected for laboratory experiments. Cultures from lactose-intolerant participants produced D- and L-lactate faster when given lactose.

The fermentation measurements came from stool cultures outside the body. They weren't measurements of this production score after a dietary intervention, and the study wasn't a randomized trial showing that changing the score improves symptoms.

Other Disease Associations

Studies have found differences in lactate-related bacteria or genes in several diseases. Their methods and populations differ, so these findings don't turn an individual production result into a disease-risk estimate.

• Gastric cancer: stool sequencing found more lactic acid bacteria and lactate-fermentation genes in people with gastric cancer than in people with chronic gastritis. This association doesn't establish that the production score can screen for stomach cancer.
• Colorectal adenomas and cancer: a study measuring lactate directly in stool found no significant difference from controls. That chemical measurement also differs from microbial production potential.
• Tuberculosis: a study of 23 people with untreated tuberculosis and 48 controls found differences in predicted microbial fermentation functions. It didn't directly establish intestinal lactate accumulation or acidosis.
• Alzheimer's disease: a study of 100 people with Alzheimer's disease and 71 controls found more lactate-producing bacterial groups in the affected participants. The findings concerned bacterial abundance and cognitive associations, without establishing that lactate production caused cognitive decline.

Age Changes the Context

Direct stool measurements in breastfed infants often show substantial lactate accumulation as their microbial communities develop. One study linked breastfeeding and fecal lactate to fewer Peptostreptococcaceae bacteria. Its laboratory experiments found that lactic acid inhibited some members of that group; this wasn't proof that raising an infant's production score prevents disease.

A separate infant cohort found a shift from propionate-producing Veillonella toward butyrate-producing Anaerobutyricum hallii as lactate consumers during the first two years. Infant findings help explain how fermentation changes with development, but they don't establish a desirable result for adults.

When Results Can Be Misleading

• Potential versus activity: DNA can identify genes associated with lactate production without showing whether those genes were active when you collected the sample.
• Production versus accumulation: a production estimate doesn't measure lactate consumption, absorption, or movement through the bowel. Even a panel containing both producer and consumer groups can't directly measure the flow between them.
• Diet and medication changes: recent dietary changes, probiotics, and antibiotics can alter the organisms detected. These changes don't have a reliably predictable effect on this score or establish that your health improved or worsened.
• Sample handling: contamination, storage conditions, and delays before preservation can affect the microbial DNA recovered. Stool consistency and bowel transit also matter when comparing samples.
• Analysis differences: DNA extraction, sequencing, and reference databases affect the result. A study that sent standardized stool material to several commercial microbiome services found substantial variation within and between providers. Scores from different methods aren't interchangeable.

Interpreting Changes Over Time

In a year-long study of 75 adults, changes within the same person accounted for 23% of variation in microbial composition, with a larger contribution for functional pathways. That finding establishes that microbiomes vary; it doesn't establish that repeated lactate-production testing improves health decisions. A changed score needs to be interpreted against changes in diet, medication, symptoms, and sample handling.